Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. - Wikidata - awgldk - TriplyDB

Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.

Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.

http://www.wikidata.org/entity/Q36594176

about

The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Evasion from NK cell-mediated immune responses by HIV-1 Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.Variations in KIR genes: a study in HIV-1 serodiscordant couples NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.Host genetics influences on HIV type-1 disease.KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa.Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers Copy number variation of KIR genes influences HIV-1 control.The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization Innate immunity against HIV: a priority target for HIV prevention research Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples.KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.KIR/HLA interactions and pathogen immunity CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function Innate immunity in acute HIV-1 infection DCs and NK cells: critical effectors in the immune response to HIV-1.Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.Innate immune control of HIV.KIR-HLA intercourse in HIV disease Structural insights into activation of antiviral NK cell responses The Yin and Yang of HLA and KIR in human disease Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.Immunogenetics of HIV disease.Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation Natural killer cells in immunodefense against infective agents.Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.

P2860

Q26753146-563BC9DF-CAE7-474C-91FA-9B4F89DFAC23 Q26864489-5D7C4129-58B5-4FA9-85C7-4E328E3C8975 Q28277389-D781277C-D3CB-4742-8F34-49180E85546A Q28483308-17EBFCA0-A53B-40DB-84DB-147A28C73F4A Q28607344-AC9F483F-5A5B-4D6F-9467-AEA24FE53937 Q30417443-91D8CA41-3100-40F6-BFA3-0BF2232840F6 Q30829234-A67C3C68-DACF-4A15-A610-A3724D5962B1 Q33609877-108308D5-B5E5-4E9E-A88D-746110510586 Q33616741-15055C56-1C50-4615-B2C6-DC115C339E69 Q33741498-43C1E732-EEF0-420B-BD79-3ECFAF6D32EA Q33775595-36034E3B-2131-4DD2-9415-F81D737EEF4F Q33827994-734A5696-714C-48CF-8233-B8E91BB7B9DA Q33828392-20A2A9C3-876D-4470-998F-809FF0255139 Q33982102-A399E81E-683A-471D-B489-F109EE1DF591 Q34090869-0B567EDD-94FE-463A-8A83-AC726AA344AF Q34234905-3350685A-1C47-447D-AE4A-93DA7CF837E4 Q34243462-97322110-92C2-4A21-BB13-5A6BDE26DA36 Q34339253-37CFDA17-64C1-4C8C-AE16-29FE42C3DFC5 Q34341384-0CBEF24F-F8CB-4A7C-9500-7834937F54B0 Q34764350-2EADBAB5-BDD8-4E89-8B52-5853D67C136A Q34995326-86B6A839-ACEF-49C8-ADB5-BC70876B2626 Q35001169-EF233CC6-7ABE-47B2-9B12-716362B8CE42 Q35121645-0EB714D9-8702-4268-9CC6-24CCE3EF2480 Q35678598-C89C7A0A-5560-4AA6-BA56-ECEE3BA867A9 Q35696991-E26C5102-95AA-434E-BC98-2ADD780C732E Q35752667-3E37BBC3-65EA-4D4D-97B8-2EF9F58FEA99 Q35846887-89855289-163F-49FF-B5A1-8765B28890CC Q36064034-98388385-4E1D-4BD4-B27A-C99CC59EBC63 Q36065864-9E777BE4-81E3-402D-A61E-3729B5CAF8B9 Q36296307-647DEFE1-6B51-4F04-8D6F-67A05F70F3EF Q36317668-30EACFC1-347C-4160-834D-BBD54C199996 Q36410540-8CC03EF6-1E16-4716-B16C-988EEA8A538F Q36471507-4D5086B5-B8F8-49E7-ABD2-CEDEEC1C7500 Q36989456-ADDF6901-9E47-4116-833D-359BCDFA0AA6 Q37021151-27442E4D-E874-4356-B933-7560EB2811BB Q37090540-E6F3CD4E-3A58-4E8B-90DF-11C6DFA8F3F9 Q37130228-F78FD715-9ADA-4138-9C60-DD9656D51C1F Q37159153-E9891C8D-4CEB-49E0-831B-B8F0B81612FF Q37178929-53F033A1-6049-420A-9D77-F461A2101BAE Q37260482-7126D577-3705-4C98-B2DD-6BDA45973D14

P2860

Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.

http://www.wikidata.org/entity/Q36594176

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Conferral of enhanced natural ...... ciency virus type 1 infection.

@ast

Conferral of enhanced natural ...... ciency virus type 1 infection.

@en

type

label

Conferral of enhanced natural ...... ciency virus type 1 infection.

@ast

Conferral of enhanced natural ...... ciency virus type 1 infection.

@en

prefLabel

Conferral of enhanced natural ...... ciency virus type 1 infection.

@ast

Conferral of enhanced natural ...... ciency virus type 1 infection.

@en

P1433

Q36594176-7373BF7D-1014-40A4-B0ED-B5319CFDE67C

P1476

Q36594176-C976B7FF-8506-4507-8B49-59C20FD1C927

P2093

Q36594176-2C3590C8-44FE-4FEF-AA7F-6C4FB8ED8BB7

Q36594176-39FDF5A6-202E-4D81-BF97-0498292AFCE3

Q36594176-3F869834-E21F-446D-9C64-F71982B45B84

Q36594176-9DD39C0E-789E-48AA-8E4F-158A5849C823

Q36594176-E213A3AC-FFA9-4F70-923B-32CAF314FE15

P2860

Q36594176-04C9D981-FA71-4077-8E78-5766E8FC053C

Q36594176-0AA8DAC5-735B-43E1-8BF5-DD8407668A6D

Q36594176-1A399E1E-2AF3-4A0B-8A27-763B8FF8FC1D

Q36594176-1EABCF53-79DF-4FDB-A265-C5B2A06348F8

Q36594176-2D8F416A-4ED5-4392-8F9F-E477C36D18AF

Q36594176-32087DAE-B828-482D-8CD6-0BFF98932C1A

Q36594176-3C553FD8-0BF1-44D0-98C6-F873E11A40C0

Q36594176-54F3F27D-5CCE-4D92-83E2-AD62A6DC7ABB

Q36594176-5819D7A8-6280-42B3-9AD9-B02608627B98

Q36594176-5C27DCDC-AB86-4C1B-BCC7-44F962F8CBD6

P304

Q36594176-B27C1A3E-EAC8-48C4-B3E6-5367E2A39931

P31

Q36594176-71948C4B-1D53-4064-BFF0-3B2AA68AE7A0

P356

Q36594176-C5DFD67E-4406-4D3F-BB0D-CD46EF561936

P407

Q36594176-BD9FDAED-9C94-4659-844B-6FFD078EB316

P433

Q36594176-935AAF10-B5E7-4E0C-98F1-7817A21F8AD4

P478

Q36594176-7310E972-245D-4162-B950-956697B92375

P50

Q36594176-9EDA02E4-3108-4531-B1EB-FB99146F555D

Q36594176-FDC61739-1DBE-4CAC-83A4-CA251F31CAA1

P577

Q36594176-AC50515B-0E0B-4474-A838-6495519703F6

P698

Q36594176-52108409-D96D-4952-A087-8B22050FB098

P932

Q36594176-E3831453-21E2-47D2-A4AA-672EFC5E6BDE

P356

P1433

Journal of Virology

P1476

Conferral of enhanced natural ...... ciency virus type 1 infection.

@en

P2093

Brian R Long

http://www.w3.org/2001/XMLSchema#string

Jason D Barbour

http://www.w3.org/2001/XMLSchema#string

Jorge R Oksenberg

http://www.w3.org/2001/XMLSchema#string

Lewis L Lanier

http://www.w3.org/2001/XMLSchema#string

Lishomwa C Ndhlovu

http://www.w3.org/2001/XMLSchema#string

P2860

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation

Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection

NK cell recognition

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.

P304

4785-4792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02449-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Douglas F. Nixon

Frederick M. Hecht

P577

2008-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18305035

http://www.w3.org/2001/XMLSchema#string

P932

2346752

http://www.w3.org/2001/XMLSchema#string